Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 4,457 | 9,751 | 9,167 | 4,334 | 5,855 |
| Cost of Goods | 2,554 | 5,150 | 4,773 | 2,290 | 3,108 |
| Gross Profit | 1,903 | 4,601 | 4,394 | 2,044 | 2,747 |
| Operating Expenses | 8,669 | 7,861 | 7,048 | 18,439 | 6,542 |
| Operating Income | -6,212 | -3,110 | -1,881 | -16,105 | -3,687 |
| Interest Expense | 38 | 33 | 89 | 86 | 85 |
| Other Income | 5,400 | 8,734 | -12,531 | 185 | 155 |
| Pre-tax Income | -850 | 5,591 | -14,501 | -16,006 | -3,617 |
| Income Tax | N/A | 30 | 5 | 6 | 44 |
| Net Income Continuous | -850 | 5,561 | -14,506 | -16,012 | -3,661 |
| Net Income | $-850 | $5,561 | $-14,506 | $-16,012 | $-3,661 |
| EPS Basic Total Ops | -0.90 | 6.60 | -27.60 | -40.00 | -9.20 |
| EPS Basic Continuous Ops | -0.90 | 6.50 | -27.61 | -40.03 | -9.15 |
| EPS Diluted Total Ops | -0.90 | 6.40 | -27.60 | -40.00 | -9.20 |
| EPS Diluted Continuous Ops | -0.90 | 6.49 | -27.61 | -40.03 | -9.15 |
| EBITDA(a) | $-6,080 | $-2,979 | $-1,750 | $-15,971 | $-3,550 |